Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

AskMen.com Jacob Franek	Future Cures Almost every disease known to man is under constant research and we can hardly go a day without hearing about some advancement or another. Here are a few diseases for which future cures could be looming on the horizon.
Bio-IT World March 17, 2004	Systems Biology: Top-Down or Bottom-Up? Systems biology involves the representation and analysis of an intact biological system. Like many of the technological developments over the past 20 years, such as genomics, proteomics, combinatorial chemistry, and bioinformatics, pharma and medical communities hold high hopes that systems biology will help move molecular research closer to the practice of medicine.
Wired March 23, 2009 Jonah Lehrer	Scientists Map the Brain, Gene by Gene I'm in the dissection room of the Allen Institute for Brain Science in Seattle, and the scientist next to me is in a hurry.
Bio-IT World January 21, 2005 Kevin Davies	Allen Brain Institute Debuts 'Google for Gene Activity' The Allen Institute for Brain Science has released its first set of gene-expression data in the brain for nearly 2,000 mouse genes. The data will have important relevance for the study of brain function, disease, and the role of genes in governing human behavior.
Bio-IT World October 2006 Catherine Varmazis	Completion of Allen Brain Atlas Hailed as 'Epoch-Making' The Allen Brain Atlas is a Web-based, graphic 3-D database of the mouse brain that shows the location of expression sites of more than 21,000 genes at the cellular level. The completion of this database has important implications for research into neurological disorders that affect humans.
HHMI Bulletin May 2010 Ivan Arnato	Light Moves Light is becoming the tool of choice for researchers who want to precisely manipulate neurons and other cells.
HHMI Bulletin February 2011 Brian Vastag	Hope Floats With a new arsenal of robust models of ALS, drug development may move to the fast track.
HHMI Bulletin May 2011 Corinna Wu	Mouse Cam Tracking techniques offer a long-term view into the mouse brain.
Teacher Magazine May 2000	Brainiacs While fanfare may feed the egos of brain researchers, it worries them, too. According to some scientists, brain research is being oversimplified, misinterpreted, and, most troubling, misapplied.
Bio-IT World November 14, 2003 Kathy Ordonez	Targeted Medicine via Molecular Diagnostics Using diagnostics to select and deselect target populations for drug therapy will enable life scientists to make more effective medicines.
Chemistry World February 24, 2011 Carl Saxton	Mapping brain networks US scientists have created a model of the ring-shaped networks of neurons in the brain, which could help researchers to understand small changes within diseased brain cells.
BusinessWeek June 13, 2005 John Carey	The NIH's Roadmap for Research Charting the human genome was just the beginning. Now the focus is creating pathways that will lead to practical applications.
HHMI Bulletin Feb 2012 Paul Muhlrad	Changing Channels Appetite and other deep-seated desires could be modified by altering brain ion channels, according to research at Janelia Farm.
HHMI Bulletin Feb 2012	President's Letter: Fundamentals for Uncertain Times The challenges in the scientific community are numerous.
Pharmaceutical Executive June 1, 2006 Nancy Dreyer	Personalized Medicine Meets the Real World A wave of genomic medicines is coming down the pipeline, and they're going to be expensive. Can companies prove they're worth it? Maybe: but the claims payers seek aren't coming from traditional clinical trials.
The Motley Fool April 27, 2011 Arundhati Parmar	Medtronic and Eli Lilly Join Hands to Combat Parkinson's Disease The partnership aims to research and develop a new approach to treating the debilitating disease.
Chemistry World July 3, 2014 Maria Burke	Renewed focus on dementia checked by drug challenges The risks and barriers for companies working in dementia are huge, but so too, potentially, are the rewards, says Simon Ridley, head of research at Alzheimer's Research UK.
HHMI Bulletin Feb 2012 Jim Keeley	International Early Career Awards Provide Connections and Funding Twenty-eight scientists from 12 countries receive inaugural award.
Chemistry World February 4, 2014 Kirsty Muirhead	Co-localization sheds light on mechanisms underlying Parkinson's disease Researchers in Australia have unveiled an immune-labelling and imaging mass spectrometry technique to demonstrate the interaction of iron and dopamine in the brain of a Parkinson's disease mouse model.
American Family Physician December 15, 2006	Parkinson's Disease: What You Should Know What is Parkinson's disease?... How can I tell if I have Parkinson's disease?... How will my doctor know if I have it?... How is Parkinson's disease treated?... etc.
BusinessWeek May 24, 2004 Arlene Weintraub	Regenerative Medicine's Slow Start Scientists think proteins that spur the body to heal could make powerful drugs, but harnessing that potential has been tough
AFP eWire August 9, 2011	What is Your Funding Strategy? Find out how your organization fits into these models so you can better articulate your funding strategy to funders and constituents.
Fast Company Christina Farr	AHA, Alphabet Set Aside $75 Million To Cure Coronary Heart Disease The American Heart Association, Verily (the company formerly known as Google Life Sciences), and European pharmaceutical giant AstraZeneca are investing the funds over a five-year period.
Managed Care September 2005 Thomas Morrow	Dual-Treatment Approach to Parkinson's Disease The treatment of Parkinson's disease is complicated. Patients may benefit from a dual approach that uses medical therapy with new innovative treatment systems.
Chemistry World January 3, 2007 Victoria Gill	Alzheimer's Protein Fingerprint Alzheimer's disease, a debilitating neurodegenerative disorder that eventually results in wasting of the whole brain, offers a chemical clue that should make it easier to spot and possibly easier to treat.
ifeminists February 16, 2005 Byron Fraser	Marginalized No Longer! In Broken Brains or Wounded Hearts--What Causes Mental Illness, Ty C. Colbert elucidates his very innovative concept of a forced choice: the emotional pain model does not lay the blame on the individual, but eventually opens the door for him to take charge of his own life and set of choices.
Scientific American June 2009 Melinda Wenner	Genetic Copy Variations and Disease A new sense for how variable numbers of genes cause disease.
AskMen.com Jacob Franek	Alzheimer's Disease 101 It's only in the last decade or so that we have truly come to understand the various disorders of the brain that are associated with age and, in most cases, Alzheimer's disease is the prime suspect. Read on for some basic information.
Chemistry World July 2010 Hayley Birch	Special Report: Health breakthroughs of the decade New discoveries have been made with cancer vaccines, genomics, statin drugs, allosteric modulators, and RNA interference during the last decade.
BusinessWeek January 8, 2007 Catherine Arnst	Decoding Alzheimer's After a century, promising treatments at last - and whispers of a cure.
BusinessWeek May 24, 2004	Michael J. Fox's Take on Stem Cells Opposition to this research is "ridiculous," says the actor. It will happen "in other countries now, and we won't have as much input"
Bio-IT World July 11, 2002 Stephen T.C. Wong	Neuro-IT Needs Integrated Infrastructure There are two major motivations for merging enterprise solutions into clinical neuroscience. The first is the need to scale up the capacity for data management. The second is the economic benefits of data sharing, software reuse, and infrastructure build-out while reducing costs.
HBS Working Knowledge November 17, 2003 Martha Lagace	The Business Case for Diabetes Disease Management Diabetes is a tough disease to tackle. A case-study discussion led by Harvard professor Nancy Beaulieu asked why it is so complex for business and society, and what might be done to curb its incidence.
Wired August 2001 Jennifer Kahn	Let's Make Your Head Interactive The Human Brain Project is combining wet anatomy with next-gen scanning, imaging, and networking to give neuroscience a revolutionary new tool -- the globally accessible online mind...
Pharmaceutical Executive February 1, 2007 Iaquinto & Palmisano	Medical Education: A Platform for Success By pumping the science behind a brand, pharmaceutical companies can garner early loyalist - before a drug even hits the market.
BusinessWeek March 7, 2005 Arlene Weintraub	Mad Cow's Stubborn Mystery Scientists still know far too little about the disease -- and the feds are making rules in the dark. Many uncertainties are in the spotlight right now as the Agriculture Dept. prepares to resume trading of some live cows and packaged beef with Canada.
HHMI Bulletin Fall 2012 R. John Davenport	Hanchuan Peng: SmartScopes Even when he launched his career as an engineer and computer scientist, Hanchuan Peng was drawn to the beauty of biology. He is a leader in developing sophisticated ways to make sense of biological images.
Bio-IT World August 13, 2003 Wendy Wolfson	Orphan Drugs: For Love or Money? Entrepreneurs organize to work toward cures for rare 'orphan' diseases.
Popular Mechanics November 12, 2009 Bijal P. Trivedi	5 Animal Genomes That May Hold Cures to Human Diseases Having the genomic information will guide pharmaceutical assessments and new experimental gene therapies, many of which are being done in animals.
American Family Physician June 1, 2002 Jeffrey L. Cummings	Guidelines for Managing Alzheimer's Disease: Part I. Assessment Family physicians play a key role in assessing and managing patients with Alzheimer's disease and in linking the families of these patients to supportive services within the community.
HHMI Bulletin May 2012 Nicole Kresge	Locating a Genetic Glitch A team of 41 scientists led by HHMI investigator Louis Ptacek has pinpointed the gene responsible for a rare disease that causes sudden, uncontrollable movements. The culprit is a little known protein that may be responsible for communication between neurons.
Chemistry World November 16, 2011 Helen Potter	Early diagnosis for Alzheimer's and Parkinson's US scientists have developed a biosensor that could detect the early stages of Alzheimer's disease and Parkinson's disease by measuring low concentrations of protein aggregates in cerebrospinal fluid.
Chemistry World February 6, 2015 Anthony King	Review plots path to face down antimicrobial resistance deaths The second installment of a UK government review on antimicrobial resistance has called for governments around the world to focus on 'easy wins' in the fight against microbial resistance.
Psychology Today May/Jun 2008 Pamela Weintraub	Lyme Disease: The Great Imitator Lyme disease can masquerade as a host of psychiatric ills, confounding doctors and driving patients to question their very sanity.
Chemistry World December 21, 2006 Tom Westgate	Molecular Probe Identifies Patients at Risk of Alzheimer's A new molecule could provide an early warning system for Alzheimer's disease, US researchers hope.
Chemistry World December 24, 2014 Phillip Broadwith	EU recommends Parkinson's drug for approval The first new drug in 10 years for Parkinson's disease has been recommended for approval by the European Committee for Medicinal Products for Human Use.
Managed Care March 2000 Steve Heimoff	Getting Out From Under Drug Companies' Shadows The perception that disease management is merely a drug marketing tool seems finally to have vanished from this healthy, though fragmented, industry.
HHMI Bulletin Winter 2013 Rabiya Tuma	Sister Act As a systems neuroscientist, Yang Dan integrates functional studies in animals with computer programs, computational tools, and statistics.
Bio-IT World June 2005 Nancy J. Kelley	Building Centers of Excellence in Translational Medicine New approaches to drug development that will be more effective in translating research to patient delivery will require the design and construction of new facilities that foster new ways of working among larger, multidisciplinary, teams of scientists and medical professionals in biology, chemistry, physics, mathematics, engineering, computer science, and, of course, information technology.
American Family Physician December 15, 2005 Meredith Desmond	Quantum Sufficit - Just Enough Does having a better education help you sleep at night?... If it seems that men just aren't listening, there could be a physical explanation... Exercise in middle age may be the key to fighting Alzheimer's disease... etc.